Citizens analyst Daniel Stauder reiterated a Market Outperform rating and $127.00 price target on LeMaitre Vascular (NASDAQ: LMAT).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE